These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1782089)

  • 1. Phase II study of combination vincristine, epirubicin and cyclophosphamide in advanced breast cancer in Chinese patients.
    Shiu W; Tao M; Leung T
    Eur J Cancer; 1991; 27(12):1710. PubMed ID: 1782089
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: preliminary data of a phase-II study.
    Nagel GA; Rauschning W; Ammon A; Beyer JH; Emrich D; Holtkamp W; Kneba M; Luig H; Marschner N; Unger C
    Onkologie; 1988 Dec; 11(6):289-91. PubMed ID: 3071765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epirubicin in combination chemotherapy of metastasized breast cancer (VEC) and advanced ovarian cancer (PEC)].
    Christmann D
    Onkologie; 1986 Aug; 9 Suppl 1():11-2. PubMed ID: 3528966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study.
    Gardin G; Barone C; Nascimben O; Ianniello G; Sturba F; Contu A; Pronzato P; Rosso R
    Eur J Cancer; 1996 Jan; 32A(1):176-7. PubMed ID: 8695230
    [No Abstract]   [Full Text] [Related]  

  • 5. Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial.
    Kretzschmar A; Drings P
    Onkologie; 1990 Apr; 13(2):141-2. PubMed ID: 2165228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose epirubicin in combination with cyclophosphamide (HD-EC) in advanced breast cancer: final results of a dose finding study and phase II trial.
    Marschner N; Nagel GA; Beyer JH; Adler M; Ammon A
    Onkologie; 1990 Aug; 13(4):272-8. PubMed ID: 2234780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of advanced cancer of the breast with FEC polychemotherapy using epirubicin at 75 mg/m2 dose (FEC 75)].
    Perez Carrion R; Jimeno JM; Jimenez V; Guardiola L; Donnay O; Sanchez J
    Bull Cancer; 1990; 77(10):1033-5. PubMed ID: 2249014
    [No Abstract]   [Full Text] [Related]  

  • 8. Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer.
    Hirano A; Shimizu T; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Aiba M; Ogawa K
    Anticancer Res; 2008; 28(6B):4137-42. PubMed ID: 19192673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
    Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
    Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
    Jassem J; Karnicka-Młodkowska H; Drozd-Lula M; Strug A; Pilarska-Machowicz A; Michalski A; Kowal E; Moś-Antkowiak R; Zych J
    Eur J Cancer; 1992; 28(2-3):473-6. PubMed ID: 1317199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer.
    Riccardi A; Giordano M; Brugnatelli S; Ucci G; Danova M; Mora O; Fava S; Ascari E
    Eur J Cancer; 1995; 31A(9):1549-51. PubMed ID: 7577090
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: preliminary results.
    Zaniboni A; Marpicati P; Simoncini E; Gorni F; Ferrari V; Raffaglio E; Garattini MP; Marini G
    Anticancer Res; 1987; 7(4B):813-5. PubMed ID: 3479042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Polverino W; Muto P; Zarrilli D
    Haematologica; 1988; 73(6):509-12. PubMed ID: 3148514
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer].
    Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3277-81. PubMed ID: 3143311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
    Gregory RK; Johnston SR; Smith IE; Miles D
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):47-9. PubMed ID: 11098493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
    Polyzos A; Malamos N; Boukovinas I; Adamou A; Ziras N; Kalbakis K; Kakolyris S; Syrigos K; Papakotoulas P; Kouroussis C; Karvounis N; Vamvakas L; Christophyllakis C; Athanasiadis A; Varthalitis I; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2010 Jan; 119(1):95-104. PubMed ID: 19636702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
    Br J Cancer; 1995 Nov; 72(5):1245-50. PubMed ID: 7577476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
    Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 20. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
    Bezwoda WR; Dansey R; Seymour L
    Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.